Adenovirus-mediated gene transfer of glial cell line-derived neurotrophic factor prevents ischemic brain injury after transient middle cerebral artery occlusion in rats

Hisashi Kitagawa, Chihoko Sasaki, Kenichi Sakai, Atsushi Mori, Yasuhide Mitsumoto, Toyoki Mori, Yoshimosuke Fukuchi, Yasuhiro Setoguchi, Koji Abe

Research output: Contribution to journalArticle

84 Citations (Scopus)


To examine a possible protective effect of exogenous glial cell line- derived neurotrophic factor (GDNF) gene expression against ischemic brain injury, a replication-defective adenoviral vector containing GDNF gene (Ad- GDNF) was directly injected into the cerebral cortex at 1 day before 90 minutes of transient middle cerebral artery occlusion (MCAO) in rats. 2,3,5- Triphenyltetrazolium chloride staining showed that infarct volume of the Ad- GDNF-injected group at 24 hours after the transient MCAO was significantly smaller than that of vehicle- or Ad-LacZ-treated group. Enzyme-linked immunosorbent assay (ELISA) for immunoreactive GDNF demonstrated that GDNF gene products in the Ad-GDNF-injected group were higher than those of vehicle-treated group at 24 hours after transient MCAO. Immunoreactive GDNF staining was obviously detected in the cortex around the needle track just before or 24 hours after MCAO in the Ad-GDNF group, whereas no or slight GDNF staining was detected in the vehicle group. The numbers of TUNEL, immunoreactive caspase-3, and cytochrome c-positive neurons induced in the ipsilateral cerebral cortex at 24 hours after transient MCAO were markedly reduced by the Ad-GDNF group. These results suggest that the successful exogenous GDNF gene transfer ameliorates ischemic brain injury after transient MCAO in association with the reduction of apoptotic signals.

Original languageEnglish
Pages (from-to)1336-1344
Number of pages9
JournalJournal of Cerebral Blood Flow and Metabolism
Issue number12
Publication statusPublished - 1999



  • Caspase-3
  • Cytochrome c
  • Gene therapy
  • Glial cell line-derived neurotrophic factor (GDNF)
  • Middle cerebral artery occlusion
  • Terminal deoxynucleotidyl dUTP nick-end labeling (TUNEL)

ASJC Scopus subject areas

  • Endocrinology
  • Neuroscience(all)
  • Endocrinology, Diabetes and Metabolism

Cite this